Skip to main content

MoneyWorks4Me

Kabra Drugs informs about board meeting

24 Jan 2019 Evaluate

Pursuant to regulation 29 of SEBI (LODR), Regulation, 2015, Kabra Drugs has informed that the meeting of the Board of Directors of the company will be held on Friday, February 01, 2019, to consider the Un-Audited financial results of the company for quarter ending December 31, 2018.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1905.00
Dr. Reddys Labs. 1385.00
Cipla 1406.00
Lupin 2012.00
Zydus Lifesciences 1213.05
View more..